Cytosorbents (CTSO) Change in Receivables (2011 - 2026)
Cytosorbents' (CTSO) quarterly Change in Receivables came in at -$310000.0 in Q1 2026, down 487.5% YoY from $80000.0 in Q1 2025, and down 326.28% on a QoQ basis from $137000.0 in Q4 2025.
Cytosorbents (CTSO) Change in Receivables (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Change in Receivables data on file, last reported at -$310000.0 in Q1 2026.
- Quarterly Change in Receivables fell 487.5% year-over-year to -$310000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$813000.0 (down 185.43% YoY) and the FY2025 annual result came in at -$423000.0, down 124.59% from the prior year.
- Change in Receivables eased to -$310000.0 in Q1 2026, from $137000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.4 million in Q2 2023 to a low of -$1.3 million in Q3 2024.
- A 5-year average of $148296.4 and a median of $80000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables surged 752.71% — and 2023, when it sank 701.71%.
- Tracing CTSO's Change in Receivables over 5 years: stood at $428400.0 in 2022, then tumbled by 183.49% to -$357670.0 in 2023, then surged by 405.03% to $1.1 million in 2024, then sank by 87.44% to $137000.0 in 2025, then slumped by 326.28% to -$310000.0 in 2026.
- The last three Change in Receivables figures came in at -$310000.0 (Q1 2026), $137000.0 (Q4 2025), and -$303000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | -67,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -67,000.00 |
| Jun 30, 2026 | -67,000.00 |
| Mar 31, 2026 | -310,000.00 |
| Mar 31, 2026 | -310,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | -303,000.00 |
| Sep 30, 2025 | -303,000.00 |
| Jun 30, 2025 | -337,000.00 |
| Jun 30, 2025 | -337,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 1.09 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 848,330.00 |
| Mar 31, 2024 | 848,330.00 |